These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 22796183)

  • 1. Synthesis and evaluation of a novel 68Ga-labeled DOTA-benzamide derivative for malignant melanoma imaging.
    Kim HJ; Kim DY; Park JH; Yang SD; Hur MG; Min JJ; Yu KH
    Bioorg Med Chem Lett; 2012 Aug; 22(16):5288-92. PubMed ID: 22796183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and characterization of a (68)Ga-labeled N-(2-diethylaminoethyl)benzamide derivative as potential PET probe for malignant melanoma.
    Kim HJ; Kim DY; Park JH; Yang SD; Hur MG; Min JJ; Yu KH
    Bioorg Med Chem; 2012 Aug; 20(16):4915-20. PubMed ID: 22831797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative preclinical evaluation of
    Trencsényi G; Dénes N; Nagy G; Kis A; Vida A; Farkas F; Szabó JP; Kovács T; Berényi E; Garai I; Bai P; Hunyadi J; Kertész I
    J Pharm Biomed Anal; 2017 May; 139():54-64. PubMed ID: 28273651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and characterization of a novel Al(18)F-NOTA-BZA conjugate for melanin-targeted imaging of malignant melanoma.
    Chang CC; Chang CH; Lo YH; Lin MH; Shen CC; Liu RS; Wang HE; Chen CL
    Bioorg Med Chem Lett; 2016 Aug; 26(16):4133-9. PubMed ID: 27445169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical evaluation of melanocortin-1 receptor (MC1-R) specific
    Nagy G; Dénes N; Kis A; Szabó JP; Berényi E; Garai I; Bai P; Hajdu I; Szikra D; Trencsényi G
    Eur J Pharm Sci; 2017 Aug; 106():336-344. PubMed ID: 28625749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and Preclinical Evaluation of a
    Wang T; Xu P; Fang J; Li C; Zeng X; Liu J; Meng L; Zhuang R; Zhang X; Su X; Guo Z
    Mol Pharm; 2023 Feb; 20(2):1015-1024. PubMed ID: 36562303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of ¹²³/¹³¹I-Iochlonicotinamide as a novel SPECT probe for malignant melanoma.
    Chang CC; Chang CH; Shen CC; Chen CL; Liu RS; Lin MH; Wang HE
    Bioorg Med Chem; 2015 May; 23(9):2261-9. PubMed ID: 25800432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Evaluation of Using NOTA and DOTA Derivatives as Bifunctional Chelating Agents in the Preparation of
    Guleria M; Das T; Amirdhanayagam J; Sarma HD; Dash A
    Cancer Biother Radiopharm; 2018 Feb; 33(1):8-16. PubMed ID: 29373046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A gallium-labeled DOTA-alpha-melanocyte- stimulating hormone analog for PET imaging of melanoma metastases.
    Froidevaux S; Calame-Christe M; Schuhmacher J; Tanner H; Saffrich R; Henze M; Eberle AN
    J Nucl Med; 2004 Jan; 45(1):116-23. PubMed ID: 14734683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of high-specific-activity (68)Ga-labeled DOTA-rhenium-cyclized alpha-MSH peptide analog to target MC1 receptors overexpressed by melanoma tumors.
    Cantorias MV; Figueroa SD; Quinn TP; Lever JR; Hoffman TJ; Watkinson LD; Carmack TL; Cutler CS
    Nucl Med Biol; 2009 Jul; 36(5):505-13. PubMed ID: 19520291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of 68Ga labeled bis-DOTA-3,3'-(benzylidene)-bis-(1H-indole-2-carbohydrazide) as a PET tracer for in vivo visualization of necrosis.
    Prinsen K; Cona MM; Cleynhens J; Vanbilloen H; Li J; Dyubankova N; Lescrinier E; Bormans G; Ni Y; Verbruggen A
    Bioorg Med Chem Lett; 2013 Jun; 23(11):3216-20. PubMed ID: 23635829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of (68)Ga- and (177)Lu-DOTA-PEG4-LLP2A for VLA-4-Targeted PET Imaging and Treatment of Metastatic Melanoma.
    Beaino W; Nedrow JR; Anderson CJ
    Mol Pharm; 2015 Jun; 12(6):1929-38. PubMed ID: 25919487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and Evaluation of Ga-68-Labeled Rhein for Early Assessment of Treatment-Induced Tumor Necrosis.
    Zhang A; Wu T; Bian L; Li P; Liu Q; Zhang D; Jin Q; Zhang J; Huang G; Song S
    Mol Imaging Biol; 2020 Jun; 22(3):515-525. PubMed ID: 31250330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and preclinical evaluation of (66)Ga-DOTA-E(c(RGDfK))2 as a potential theranostic radiopharmaceutical.
    Lopez-Rodriguez V; Gaspar-Carcamo RE; Pedraza-Lopez M; Rojas-Calderon EL; Arteaga de Murphy C; Ferro-Flores G; Avila-Rodriguez MA
    Nucl Med Biol; 2015 Feb; 42(2):109-14. PubMed ID: 25316595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of novel radioiodinated benzamides for malignant melanoma.
    Pham TQ; Greguric I; Liu X; Berghofer P; Ballantyne P; Chapman J; Mattner F; Dikic B; Jackson T; Loc'h C; Katsifis A
    J Med Chem; 2007 Jul; 50(15):3561-72. PubMed ID: 17602544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of 68Ga-bis-DOTA-PA as a potential agent for positron emission tomography imaging of necrosis.
    Prinsen K; Cona MM; Cleynhens BJ; Li J; Vanbilloen H; Dyubankova N; Lescrinier E; Ni Y; Bormans GM; Verbruggen AM
    Nucl Med Biol; 2013 Aug; 40(6):816-22. PubMed ID: 23915800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of 68Ga-labeled DOTA-nitroimidazole derivatives and their feasibilities as hypoxia imaging PET tracers.
    Hoigebazar L; Jeong JM; Hong MK; Kim YJ; Lee JY; Shetty D; Lee YS; Lee DS; Chung JK; Lee MC
    Bioorg Med Chem; 2011 Apr; 19(7):2176-81. PubMed ID: 21419635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 68Ga-DOTA-NGR as a novel molecular probe for APN-positive tumor imaging using MicroPET.
    Zhang J; Lu X; Wan N; Hua Z; Wang Z; Huang H; Yang M; Wang F
    Nucl Med Biol; 2014 Mar; 41(3):268-75. PubMed ID: 24438818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and evaluation of a radiogallium complex-conjugated bisphosphonate as a bone scintigraphy agent.
    Ogawa K; Takai K; Kanbara H; Kiwada T; Kitamura Y; Shiba K; Odani A
    Nucl Med Biol; 2011 Jul; 38(5):631-6. PubMed ID: 21718937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET imaging of very late antigen-4 in melanoma: comparison of 68Ga- and 64Cu-labeled NODAGA and CB-TE1A1P-LLP2A conjugates.
    Beaino W; Anderson CJ
    J Nucl Med; 2014 Nov; 55(11):1856-63. PubMed ID: 25256059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.